Cardiovascular and renal outcomes with SGLT-2 inhibitors versus GLP-1 receptor agonists in patients with type 2 diabetes mellitus and chronic kidney disease: a systematic review and network meta-analysis
What to do: Eat a balanced diet with enough protein, vitamins, and minerals, and check in with your provider if shedding continues or worsens
deductible plus coinsurance for an infusion day)
Since retatrutide is another GLP-1 agonist, it is likely to be unsuitable for those with a family history of thyroid cancer and anyone with multiple endocrine neoplasia syndrome type 2
The big clinical point is that hormonal imbalance weight gain is not only about appearance
When used alongside GLP-1 receptor agonists, this could theoretically provide additive glucose-lowering effects without increasing hypoglycaemia risk for most patients, as both agents work through glucose-dependent mechanisms